Keywords: buys, centocor, billion, stock, swap, profits, up
J&J buys Centocor in $4.9 billion stock swap, profits up 15%
Article | 22 July 1999
Johnson & Johnson has entered into a definitive agreement to purchaseCentocor in a stock-for-stock exchange valued at $4.9 billion, based upon Centocor's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
